The Treatment of Cartilaginous Lesions and Concomitant Anterior Cruciate Ligament Reconstruction
Randomized Study on the Treatment of Cartilaginous Lesions and Concomitant Anterior Cruciate Ligament Reconstruction
1 other identifier
interventional
88
1 country
1
Brief Summary
The aim of the study is the evaluation of both clinical and radiological results in patients undergone to cruciate ligament reconstruction with concomitant cartilaginous lesion treated with or without nanofractures.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jul 2019
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 25, 2019
CompletedFirst Submitted
Initial submission to the registry
November 28, 2019
CompletedFirst Posted
Study publicly available on registry
December 3, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 25, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 25, 2027
May 18, 2025
May 1, 2025
8 years
November 28, 2019
May 16, 2025
Conditions
Outcome Measures
Primary Outcomes (2)
IKDC-subjective score (International Knee Documentation Committee)
It is a specific subjective rating scale for te knee. Iti s one of the most reliable tools for assessing knee diseases. The survey examines three categories: symptoms, sport activity, knee function.
24 month
WORMS (Whole-Organ Magnetic Resonance Imaging Score)
Magnetic resonance imaging will be evaluated through WORMS. The score evaluated five aspects of the three knee compartments (cartilage, bone marrow abnormalities, bone cysts, bone attrition and osteophytes) as well as the soft tissue (menisci, ligaments and synovium)
24 month
Secondary Outcomes (4)
IKDC-subjective score (International Knee Documentation Committee)
6, 12, 36 and 60 months
Tegner Activity Level Scale
6, 12, 24, 36 and 60 months
KOOS (Knee injury and Osteoarthritis Outcome Score )
6, 12, 24, 36 and 60 months
EQ-5D (EuroQoL) Current Health Assessment
6, 12, 24, 36 and 60 months
Study Arms (2)
Nanofractures treatment of the cartilaginous lesions
EXPERIMENTALPatients undergoing to anterior cruciate ligament reconstruction with concomitant treatment of the cartilaginous lesions with nanofractures technique.
no treatment of the cartilaginous lesions
ACTIVE COMPARATORPatients undergoing to anterior cruciate ligament reconstruction. Cartilaginous lesions won't be treated
Interventions
anterior cruciate ligament reconstruction will be performed in combination with the nanofractures for the treatment of cartilaginous lesions
patient undergoing to the anterior cruciate ligament reconstruction without treatment of the cartilaginous lesions
Eligibility Criteria
You may qualify if:
- Male or female patients, 18 \< age \< 55;
- Patients with complete ACL injury candidates for surgical reconstruction of the same;
- Cartilaginous lesion of the femur-tibial compartment of grade III-IV ICRS ≤3 cm2 confirmed intra-operatively;
- Patients without evidence of osteoarthritis
- Patients' ability and consent to participate in clinical and radiological follow-up;
- Signature of informed consent.
You may not qualify if:
- Patients incapable of understanding and of wanting;
- State of immunodepression;
- Patients with malignant neoplasms;
- Patients suffering from rheumatic diseases;
- Patients suffering from non-compensated diabetes;
- Patients suffering from uncompensated thyroid metabolic disorders;
- Patients abusing alcoholic beverages, drugs or drugs;
- Patients with axial deviations\> 5 °;
- Body Mass Index\> 35;
- Patients treated with surgery at the same knee in the previous 12 months.
- Cartilaginous lesions grade I-II according to the ICRS score.
- Cartilage lesions with a diameter greater than 3 cm².
- Non-suturable meniscal lesions requiring meniscectomy\> 50% and patients with previous meniscectomies\> 50% in the same compartment.
- Need for further associated surgical procedures in addition to the reconstruction of ACL and possibly the nanofractures.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Istituto Ortopedico Rizzoli
Bologna, Italy
Related Publications (2)
Filardo G, de Caro F, Andriolo L, Kon E, Zaffagnini S, Marcacci M. Do cartilage lesions affect the clinical outcome of anterior cruciate ligament reconstruction? A systematic review. Knee Surg Sports Traumatol Arthrosc. 2017 Oct;25(10):3061-3075. doi: 10.1007/s00167-016-4097-y. Epub 2016 Apr 4.
PMID: 27043346BACKGROUNDBrophy RH, Zeltser D, Wright RW, Flanigan D. Anterior cruciate ligament reconstruction and concomitant articular cartilage injury: incidence and treatment. Arthroscopy. 2010 Jan;26(1):112-20. doi: 10.1016/j.arthro.2009.09.002.
PMID: 20117635BACKGROUND
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 28, 2019
First Posted
December 3, 2019
Study Start
July 25, 2019
Primary Completion (Estimated)
July 25, 2027
Study Completion (Estimated)
July 25, 2027
Last Updated
May 18, 2025
Record last verified: 2025-05